University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden

Simple item page
dc.contributor.authorOrbell, Lai Yee
dc.contributor.authorAbutheraa, Nouf
dc.contributor.authorDuncombe, Andrew S.
dc.contributor.authorMcMullin, Mary Frances
dc.contributor.authorMesa, Ruben
dc.contributor.authorMcShane, Charlene
dc.contributor.authorJames, Glen
dc.contributor.authorAnderson, Lesley
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Cancer Centreen
dc.date.accessioned2024-02-23T12:01:00Z
dc.date.available2024-02-23T12:01:00Z
dc.date.issued2023-11
dc.descriptionFunding information: MPNVoice,Grant/AwardNumber:0001 Acknowledgements: The authors would like to express gratitude to the participants who gave their time to take part in the MOSAICC pilot study. We would also like to acknowledge the work of the charity MPN Voice (grant number 0001), formerly MPD Voice, who kindly funded the work of the MOSAICC pilot study. Finally, we would like to thank Dr Barry Crouch from the University of Aberdeen Digital Research Service, whose knowledge and assistance in coding and statistical software were fundamental to the completion of this research.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent701351
dc.identifier281648682
dc.identifierb1c68506-e825-4dc8-94f2-bbe1c6fb8b57
dc.identifier38024634
dc.identifier.citationOrbell, L Y, Abutheraa, N, Duncombe, A S, McMullin, M F, Mesa, R, McShane, C, James, G & Anderson, L 2023, 'The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden', European Journal of Haematology, vol. 4, no. 4, pp. 1071-1080. https://doi.org/10.1002/jha2.805en
dc.identifier.doi10.1002/jha2.805
dc.identifier.iss4en
dc.identifier.issn0902-4441
dc.identifier.otherORCID: /0000-0002-1000-3649/work/147045740
dc.identifier.otherORCID: /0000-0003-2665-5630/work/189632901
dc.identifier.urihttps://hdl.handle.net/2164/22838
dc.identifier.vol4en
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Haematologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectessential thrombocythaemiaen
dc.subjectJanus kinase 2en
dc.subjectmanagementen
dc.subjectmyeloproliferative neoplasmen
dc.subjectPolycythaemia veraen
dc.subjectprimary myelofibrosisen
dc.subjecttreatmenten
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subject.lccRC0254en
dc.titleThe JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burdenen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Orbell_etal_RJH_The_JAK2V617F_Mutation_VoR.pdf
Size:
684.91 KB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress